JPWO2020230869A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020230869A5 JPWO2020230869A5 JP2021519492A JP2021519492A JPWO2020230869A5 JP WO2020230869 A5 JPWO2020230869 A5 JP WO2020230869A5 JP 2021519492 A JP2021519492 A JP 2021519492A JP 2021519492 A JP2021519492 A JP 2021519492A JP WO2020230869 A5 JPWO2020230869 A5 JP WO2020230869A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- composition according
- therapeutic composition
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025076960A JP2025108784A (ja) | 2019-05-14 | 2025-05-02 | Ｐａｃａｐペプチド又はｐａｃａｐの安定化ペプチドを含む神経栄養性角膜炎の予防又は治療用組成物 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019091700 | 2019-05-14 | ||
| PCT/JP2020/019347 WO2020230869A1 (ja) | 2019-05-14 | 2020-05-14 | Ｐａｃａｐペプチド又はｐａｃａｐの安定化ペプチドを含む神経栄養性角膜炎の予防又は治療用組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025076960A Division JP2025108784A (ja) | 2019-05-14 | 2025-05-02 | Ｐａｃａｐペプチド又はｐａｃａｐの安定化ペプチドを含む神経栄養性角膜炎の予防又は治療用組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2020230869A1 JPWO2020230869A1 (https=) | 2020-11-19 |
| JPWO2020230869A5 true JPWO2020230869A5 (https=) | 2023-04-28 |
Family
ID=73289423
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021519492A Pending JPWO2020230869A1 (https=) | 2019-05-14 | 2020-05-14 | |
| JP2025076960A Pending JP2025108784A (ja) | 2019-05-14 | 2025-05-02 | Ｐａｃａｐペプチド又はｐａｃａｐの安定化ペプチドを含む神経栄養性角膜炎の予防又は治療用組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025076960A Pending JP2025108784A (ja) | 2019-05-14 | 2025-05-02 | Ｐａｃａｐペプチド又はｐａｃａｐの安定化ペプチドを含む神経栄養性角膜炎の予防又は治療用組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220202905A1 (https=) |
| EP (1) | EP3970796B1 (https=) |
| JP (2) | JPWO2020230869A1 (https=) |
| CN (1) | CN114173874B (https=) |
| ES (1) | ES3045907T3 (https=) |
| WO (1) | WO2020230869A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202400628A (zh) * | 2022-06-24 | 2024-01-01 | 全福生物科技股份有限公司 | 用於治療神經營養性角膜炎疾病之包含pedf衍生短肽之組合物 |
| WO2024102746A1 (en) * | 2022-11-08 | 2024-05-16 | Microcures, Inc. | Methods and agents for treating neurotrophic keratitis |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5198542A (en) * | 1989-06-20 | 1993-03-30 | Takeda Chemical Industries, Inc. | Dna encoding a pitvitary adenylate cyclase activating protein and use thereof |
| JPH10505863A (ja) * | 1994-09-22 | 1998-06-09 | ジ・アドミニストレーターズ・オブ・ザ・チューレン・エデュケイショナル・ファンド | 脳障害の予防および治療のための方法および医薬組成物 |
| US20020155533A1 (en) * | 1998-11-30 | 2002-10-24 | Takeda Chemical | PACAP receptor protein, method for preparing said protein, and use thereof |
| JP2001151799A (ja) * | 1999-11-22 | 2001-06-05 | Itoham Foods Inc | 新規ペプチド及びそれを含有する消化管運動抑制剤 |
| WO2003051387A1 (fr) * | 2001-12-19 | 2003-06-26 | Itoham Foods Inc. | Agents therapeutiques et/ou prophylactiques contre des maladies conformationnelles |
| US20060270592A1 (en) * | 2004-03-19 | 2006-11-30 | Ophthalmic Research Associates, Inc. | Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions |
| KR20070036031A (ko) * | 2004-04-23 | 2007-04-02 | 센주 세이야꾸 가부시키가이샤 | Ｐａｃａｐ 및 이의 유도체를 함유하는 각막 신경세포 형성촉진제 |
| JP2009269818A (ja) | 2006-08-22 | 2009-11-19 | Univ Showa | Ｐａｃａｐペプチドを含む眼科用剤 |
| WO2010036936A2 (en) * | 2008-09-25 | 2010-04-01 | The Administrators Of The Tulane Educational Fund | Use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with anticancer agents |
| US8916517B2 (en) * | 2009-11-02 | 2014-12-23 | The Administrators Of The Tulane Educational Fund | Analogs of pituitary adenylate cyclase-activating polypeptide (PACAP) and methods for their use |
| CN101745098A (zh) * | 2010-01-26 | 2010-06-23 | 暨南大学 | 神经多肽pacap38在制备眼部疾病的治疗、损伤修复或再生药物中的应用 |
| WO2012127475A1 (en) | 2011-03-24 | 2012-09-27 | Neurim Pharmaceuticals (1991) Ltd. | Neuroprotective peptides |
| JP5775356B2 (ja) | 2011-05-09 | 2015-09-09 | 松本 明 | 神経保護作用を有するペプチド及びこれを含む薬剤 |
| CU24075B1 (es) * | 2011-08-26 | 2015-01-29 | Ct De Ingeniería Genética Y Biotecnología | Composición vacunal que comprende el péptido activador de la adenilato ciclasa de pituitaria como adyuvante molecular. |
| CN103145851B (zh) * | 2013-02-22 | 2014-07-02 | 暨南大学 | 重组蛋白PACAP38-NtA及其编码基因与应用 |
| WO2017027848A1 (en) | 2015-08-12 | 2017-02-16 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Glycosylated peptides with pseudoproline residues and having enhanced half-lives and ability to cross the blood brain barrier |
| AT520342A1 (de) * | 2017-09-07 | 2019-03-15 | Ventrex Automotive Gmbh | Ventil zum Einsatz im Tieftemperaturbereich sowie Verwendung dieses Ventils |
-
2020
- 2020-05-14 WO PCT/JP2020/019347 patent/WO2020230869A1/ja not_active Ceased
- 2020-05-14 JP JP2021519492A patent/JPWO2020230869A1/ja active Pending
- 2020-05-14 EP EP20806275.2A patent/EP3970796B1/en active Active
- 2020-05-14 CN CN202080036430.2A patent/CN114173874B/zh active Active
- 2020-05-14 ES ES20806275T patent/ES3045907T3/es active Active
- 2020-05-14 US US17/610,844 patent/US20220202905A1/en active Pending
-
2025
- 2025-05-02 JP JP2025076960A patent/JP2025108784A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018171063A5 (https=) | ||
| JP2022503427A5 (https=) | ||
| JP2010519293A5 (https=) | ||
| JP2010518833A5 (https=) | ||
| JPWO2020230869A5 (https=) | ||
| JP2023029902A5 (https=) | ||
| Sautiere et al. | Primary structure of the ram (Ovis aries) protamine | |
| JP2013515057A5 (https=) | ||
| JP2008507298A5 (https=) | ||
| JP2007535910A5 (https=) | ||
| KR20080103511A (ko) | 신규한 펩타이드 및 이의 용도 | |
| CN104411715A (zh) | 靶向eIF4E的细胞穿透肽 | |
| JP2013509432A5 (https=) | ||
| WO1991015504A1 (en) | Method to purify basic fibroblast growth factor | |
| JPWO2018234492A5 (https=) | ||
| JP2008545393A5 (https=) | ||
| JP2008521795A5 (https=) | ||
| JP2008510468A5 (https=) | ||
| JP4303958B2 (ja) | 環状ペプチドとその調製方法並びに血管形成阻害薬又は促進薬としての用途 | |
| JP2020127419A5 (https=) | ||
| JP2004537284A5 (https=) | ||
| JP2007536910A5 (https=) | ||
| RU2010120571A (ru) | Тимус-специфический белок | |
| CN108976291A (zh) | 一种改善糖尿病和老年性痴呆的十六肽 | |
| JP2003334088A5 (https=) |